title: Daunomycin and doxorubicin Lym-1-drug conjugates for the treatment of malignant lymphomas.
authors.forename: F M
authors.initials: FM
authors.lastname: Chen
authors.forename: B
authors.initials: B
authors.lastname: LeBerthon
authors.forename: G S
authors.initials: GS
authors.lastname: Naeve
authors.forename: A L
authors.initials: AL
authors.lastname: Epstein
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000473:pathology; D002470:Cell Survival / Q000187:drug effects; D003630:Daunorubicin / Q000627:therapeutic use*; D004337:Drug Carriers; D006801:Humans; D066298:In Vitro Techniques; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D011838:Radiation-Sensitizing Agents; D003630:Daunorubicin